Overview

Detailed Summary

Archean Chemical Industries Limited is an India‑based specialty marine chemicals manufacturer producing industrial salt, liquid bromine, sulphate of potash (SOP) and bromine derivatives from integrated facilities at Hajipir with captive brine fields, port access and an R&D base; its products serve agrochemicals, pharmaceuticals, flame retardants, water treatment and global industrial customers.
The company remains heavily export‑oriented with exports contributing nearly 79% of operating revenues; consolidated 9MFY26 revenues were INR8,016.7 million (≈10.6% YoY growth) while consolidated PAT fell to INR931.8 million due to operational disruptions in bromine, higher costs and lower derivatives utilisation, highlighting resilient sales but margin pressure in FY26.
Archean is undertaking strategic diversification into advanced materials and energy: it has invested in Clas‑SiC Wafer Fab and formed SiCSem to build India’s first commercial SiC compound fab, and acquired a significant stake in Offgrid Energy Labs to commercialize zinc‑bromide batteries, signalling a deliberate strategic pivot beyond marine chemicals.
Operationally the company presents a mixed picture: industrial salt volumes surged about 39% to 3.07 million tons in 9MFY26, bromine volumes fell on technical issues but management has launched corrective projects, Acume derivatives capacity utilisation is currently low but management targets a ramp to ~60%–70% and SOP plant trials are moving from pilot to plant scale.

Sector: Chemicals & Petrochemicals
Industry: Specialty Chemicals
Market Cap: 6,357 Cr
Volatility: Low Risk
P/E Ratio: 59.8
Industry P/E: 43.0
PEG Ratio: 1.0
P/B Ratio: 3.3
52W High: 727.80
52W Low: 483.10

Sales CAGR

1Y: 3.85%
3Y: -10.26%
5Y: 7.05%
10Y: —

Profit CAGR

1Y: -34.99%
3Y: -26.17%
5Y: 18.31%
10Y: —

ROE

TTM: 5.52%
3Y: 11.85%
5Y: 16.95%
10Y: —

ROCE

TTM: 7.20%
3Y: 14.94%
5Y: 21.32%
10Y: —

Technicals

‌

Forecasts

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Peers

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
ELANTAS		10039.45	7,888 Cr	54.03	7.82	0.08	14.66	19.67	12.52
BALAMINES		2045.40	6,627 Cr	39.64	3.35	0.54	8.46	11.24	6.17
ACI		516.65	6,399 Cr	60.18	3.31	0.48	5.52	7.20	3.96
GALAXYSURF		1752.00	6,212 Cr	23.23	2.26	0.00	9.74	12.15	6.90
NEOGEN		1906.65	5,221 Cr	181.84	5.34	0.00	3.52	5.24	0.99
EPIGRAL		1159.00	5,029 Cr	15.15	2.26	0.43	14.94	14.69	9.47
FCL		40.66	4,735 Cr	43.53	5.37	0.06	12.32	17.29	10.78
Median: 7 Co.	—	1752.00	6,212 Cr	43.53	3.35	0.08	9.74	12.15	6.90

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	413	284	213	240	242	346	292	233	255	301
Expenses	267	197	141	166	162	257	214	171	200	257
Operating Profit	145	87	71	75	80	88	78	63	54	44
OPM %	35.25	30.69	33.48	31.07	32.99	25.55	26.71	26.85	21.37	14.52
Other Income	9.24	12	9.70	-29	8.85	7.81	8.23	6.38	6.95	5.39
Interest	1.90	1.70	1.70	3.21	2.91	0.29	5.38	5.52	4.42	10
Depreciation	18	18	19	19	20	21	23	24	24	23
Profit Before Tax	135	80	61	23	66	75	58	40	33	16
Tax %	24.86	27.76	25.96	30.95	27.27	28.03	30.79	27.24	27.99	22.89
Net Profit	102	58	45	16	48	54	40	29	24	12
EPS in Rs	8.23	4.64	3.64	1.27	3.88	4.33	3.25	2.36	1.92	1.12

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,130	1,441	1,330	1,041	1,081	1,121
Expenses	663	807	867	727	842	800
Operating Profit	467	634	463	314	239	321
OPM %	41.33	44.00	34.78	30.18	22.09	28.65
Other Income	12	43	43	-2.90	27	-4.37
Interest	162	97	8.46	8.10	26	12
Depreciation	67	69	70	79	93	84
Profit Before Tax	251	512	427	224	147	221
Tax %	25.02	25.23	25.33	27.54	28.34	28.82
Net Profit	188	383	319	162	105	157
EPS in Rs	—	34.03	25.76	13.12	8.65	8.65
Dividend Payout %	0.00	7.23	11.60	22.87	28.90	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	19	25	25	25	25
Reserves	243	1,406	1,677	1,839	1,910
Borrowings	897	69	98	235	466
Other Liabilities	372	255	256	295	264
Total Liabilities	1,531	1,755	2,056	2,393	2,665
Fixed Assets	1,086	1,110	1,160	1,378	1,383
CWIP	17	36	48	69	182
Investments	11	210	350	339	257
Other Assets	417	399	498	607	843
Total Assets	1,531	1,755	2,056	2,393	2,665

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	315	496	379	176	140
Cash from Investing Activity	-110	-290	-307	-246	-293
Cash from Financing Activity	-224	-212	-33	65	154
Net Cash Flow	-19	-6.23	40	-5.01	0.69

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	53.60%	53.60%	53.45%	53.45%	53.45%	53.45%	53.44%	53.44%	53.44%	53.44%	53.43%	53.43%
FIIs	4.06%	2.92%	4.15%	5.86%	9.53%	10.17%	10.65%	10.94%	11.05%	11.15%	11.08%	11.09%
DIIs	30.78%	30.47%	28.77%	27.22%	21.12%	22.01%	22.85%	23.18%	24.68%	25.52%	25.25%	25.82%
Public	11.55%	13.01%	13.63%	13.47%	15.89%	14.37%	13.06%	12.44%	10.83%	9.89%	10.25%	9.66%
Total Shareholders	62,548	73,821	92,571	1,06,788	98,762	95,999	94,958	85,856	75,697	70,852	69,900	64,925

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY26

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Available on Pro Plan